BSE
Your Result on : Company News Details
Cipla Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500087
ISIN Demat
INE059A01026
Book Value (Rs)
432.1356994
NSE Symbol
CIPLA
Divident Yield %
0.92
Market Cap
(Rs In Cr.)
114,720
P/E (TTM)
40.17
EPS (TTM)
35.35
Face Value
(Rs)
2
Back
Cipla consolidated net profit declines 35.05% in the September 2026 quarter
27-Oct-26   Hrs IST

Net profit of Cipla declined 35.05% to Rs 877.54 crore in the quarter ended September 2026 as against Rs 1351.17 crore during the previous quarter ended September 2025. Sales declined 1.06% to Rs 7368.15 crore in the quarter ended September 2026 as against Rs 7447.42 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales7368.157447.42 -1
OPM %18.8325.44 -
PBDT1522.202150.52 -29
PBT1177.341853.53 -36
NP877.541351.17 -35

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
BSE Delayed market data sourced at 5 minutes – www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)